Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated (Q98781332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

title

Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Orhun Çığ Taşkın

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Bassel F El-Rayes

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Olca Basturk

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Volkan Adsay

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

author name string

Yue Xue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Cisel Aydin Mericoz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Hongmei Jiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Burcin Pehlivanoglu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Takashi Muraki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Bahar Memis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Burcu Saka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Grace E Kim

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Sudeshna Bandopadhyay

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Jessica Knight

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Juan Sarmiento

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Michelle D Reid

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Mert Erkan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

publication date

28 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.

30 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

A Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Clinicopathologic features and prognostic analysis of MSI-high colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

The evolving role of microsatellite instability in colorectal cancer: A review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Ampullary Region Carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Mutations of the human MUT S homologue 6 gene in ampullary carcinoma and gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Adenocarcinoma of the Ampulla of Vater: T-Stage, Chromosome 17p Allelic Loss, and Extended Pancreaticoduodenectomy are Relevant Prognostic Factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Lack of microsatellite instability in neoplasms of ampulla of Vater

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Genetic instability and mutation of the TGF-beta-receptor-II gene in ampullary carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Infrequent microsatellite instability in biliary tract cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Extra-ampullary duodenal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Not all "mucinous carcinomas" are equal: time to redefine and reinvestigate the biologic significance of mucin types and patterns in the GI tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Colloid (mucinous noncystic) carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Tumor-infiltrating neutrophils in pancreatic neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Has Mismatch Repair-Deficient Cancer Met Its MATCH?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

An insight into the genetic pathway of adenocarcinoma of the small intestine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

HNPCC-associated small bowel cancer: clinical and molecular characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

The prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.33135

7 January 2021

Identifiers

DOI

10.1002/CNCR.33135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32857459%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

1 reference